Rituximab-Lenalidomide (REVRI) in Relapse or Refractory Primary Central Nervous System (PCNSL) or Vitreo Retinal Lymphoma (PVRL): Results of a 'Proof of Concept' Phase II Study of the French LOC Network

Ghesquieres Herve; Houillier Caroline; Chinot Olivier; Choquet Sylvain; Molucon-Chabrot Cecile; Beauchene Patrick; Gressin Remy; Morschhauser Franck; Schmitt Anna; Gyan Emmanuel; Hoang-Xuan Khe; Nicolas-Virelizier Emmanuelle; Chevrier Marion; Savignoni Alexia; Turbiez Isabelle; Veillas Florence; Soumelis Vassili; Soussain Carole

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Rituximab-Lenalidomide (REVRI) in Relapse or Refractory Primary Central Nervous System (PCNSL) or Vitreo Retinal Lymphoma (PVRL): Results of a 'Proof of Concept' Phase II Study of the French LOC Network

【24h】

Rituximab-Lenalidomide (REVRI) in Relapse or Refractory Primary Central Nervous System (PCNSL) or Vitreo Retinal Lymphoma (PVRL): Results of a 'Proof of Concept' Phase II Study of the French LOC Network

机译：复发或难治性原发性中枢神经系统（PCNSL）或玻璃体视网膜淋巴瘤（PVRL）复发的利妥昔单抗-来那度胺（REVRI）：法国LOC网络“概念验证” II期研究的结果

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology 》 |2016年第22期| 共5页
作者
Ghesquieres Herve; Houillier Caroline; Chinot Olivier; Choquet Sylvain; Molucon-Chabrot Cecile; Beauchene Patrick; Gressin Remy; Morschhauser Franck; Schmitt Anna; Gyan Emmanuel; Hoang-Xuan Khe; Nicolas-Virelizier Emmanuelle; Chevrier Marion; Savignoni Alexia; Turbiez Isabelle; Veillas Florence; Soumelis Vassili; Soussain Carole;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Rituximab-Lenalidomide (REVRI) in Relapse or Refractory Primary Central Nervous System (PCNSL) or Vitreo Retinal Lymphoma (PVRL): Results of a "Proof of Concept" Phase II Study of the French LOC Network [J] . Ghesquieres Herve, Houillier Caroline, Chinot Olivier, Blood: The Journal of the American Society of Hematology . 2016 ,第22期

机译：复发或难治性原发性中枢神经系统（PCNSL）或玻璃体视网膜淋巴瘤（PVRL）复发的利妥昔单抗-来那度胺（REVRI）：法国LOC网络“概念验证” II期研究的结果
2. Rituximab-Lenalidomide (REVRI) in Relapse or Refractory Primary Central Nervous System (PCNSL) or Vitreo Retinal Lymphoma (PVRL): Results of a "Proof of Concept" Phase II Study of the French LOC Network [J] . Ghesquieres Herve, Houillier Caroline, Chinot Olivier, Blood: The Journal of the American Society of Hematology . 2016 ,第22期

机译：复发或难治性原发性中枢神经系统（PCNSL）或玻璃体视网膜淋巴瘤（PVRL）复发的利妥昔单抗-来那度胺（REVRI）：法国LOC网络“概念验证” II期研究的结果
3. Ibrutinib Monotherapy in Relapse or Refractory Primary CNS Lymphoma (PCNSL) and Primary Vitreo-Retinal Lymphoma (PVRL). Result of the Interim Analysis of the iLOC Phase II Study from the Lysa and the French LOC Network [J] . Choquet Sylvain, Houillier Caroline, Bijou Fontanet, Blood: The Journal of the American Society of Hematology . 2016 ,第22期

机译：伊布洛替尼单药治疗复发或难治性原发性CNS淋巴瘤（PCNSL）和主要玻璃体视网膜淋巴瘤（PVRL）。 ilya和法国LOC网络中ILOC期II研究中临时分析的结果
4. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
5. Phase I/II study of tirabrutinib a second-generation Bruton’s tyrosine kinase inhibitor in relapsed/refractory primary central nervous system lymphoma [O] . Yoshitaka Narita, Motoo Nagane, Kazuhiko Mishima, 2021

机译：Tirabrutinib第二代Bruton的酪氨酸激酶抑制剂复发/难治原发性中枢神经系统淋巴瘤的I / II研究
6. IBRUTINIB IN RELAPSE OR REFRACTORY PRIMARY CNS AND VITREO-RETINAL LYMPHOMA. RESULTS OF THE PRIMARY END-POINT OF THE I LOC PHASE II STUDY FROM THE LYSA AND THE FRENCH LOC NETWORK. [O] . C. Soussain, S. Choquet, C. Houillier, 2017

机译：伊布洛替尼在复发或难治性原发性CNS和玻璃体视网膜淋巴瘤中。 LEC阶段II的主要终点结果从LYSA和法国LOC网络研究。

Rituximab-Lenalidomide (REVRI) in Relapse or Refractory Primary Central Nervous System (PCNSL) or Vitreo Retinal Lymphoma (PVRL): Results of a 'Proof of Concept' Phase II Study of the French LOC Network

著录项

相似文献

相关主题

期刊订阅